- Vevizye contains ciclosporin 1mg/mL in a preservative-free, phosphate-free, multi-dose eye drop formulation¹

- Ciclosporin is a calcineurin inhibitor with anti-inflammatory and immunosuppressant properties¹

Vevizye is indicated for the treatment of moderate to severe dry eye disease (keratoconjunctivitis sicca) in adult patients, which has not improved despite treatment with tear substitutes¹. The water-free vehicle has specific properties which reduce friction, enhance spreading (thereby contributing to efficacy) and enable Vevizye to be preservative-free and phosphate-free.¹.

Vevizye has been shown to have a fast onset of action with significant improvements in total Corneal Fluorescein Staining (tCFS) in 2 weeks² which are maintained over 12 months³. After 1 month over 70% of patients had more than 3 grades improvement in tCFS scores².

Studies have shown that Vevizye is well tolerated with high patient satisfaction and low side effect profile³. Installation site pain was the most commonly reported at 7.9%.¹